白质变化在帕金森病中的变化
Kai Yang1, Zhengqi Wu2, Jie Long2
1School of Chemistry, Chemical Engineering and Life Science, Wuhan University of Technology, 122 Luoshi Road, Wuhan, 430070, People's Republic of China. kyang43@whut.edu.cn.
NPJ Parkinson's disease
|November 1, 2023
概括
白质变化,特别是涉及髓和寡细胞,越来越多地被认为是帕金森病 (PD) 病理学中的重要变化. 这些异常与PD症状相关,可能提供新的治疗点.
科学领域:
- 神经科学是一个神经科学.
- 神经学 神经学
- 病理学 病理学 病理学
背景情况:
- 帕金森病 (PD) 是一种流行的神经退行性疾病,仅次于阿尔茨海默病 (AD).
- 典型地,PD是由 substantia nigra pars compacta 和 Lewy 体形成中的多巴胺基神经元损失所定义的.
- 虽然传统上被视为灰质 (GM) 疾病,但最近的研究强调了白质 (WM) 改变在PD中的作用.
研究的目的:
- 审查磁共振成像 (MRI) 证据,证明PD中的WM异常.
- 探索WM变化与特定PD症状之间的相关性.
- 总结一下关于PD中的寡细胞 (OLs) /髓变化的分子研究.
主要方法:
- 对磁共振成像 (MRI) 研究的综述,研究帕金森病中的白质.
- 对转录组和全基因组研究的分析,检查PD中的寡腺细胞和髓蛋白变化.
- 白质变化与帕金森病临床症状之间的相关性分析.
主要成果:
- 核磁共振成像 (MRI) 证据表明,帕金森病患者中普遍存在白质异常.
- 特定的白质变化与PD的明显的运动和非运动症状有关.
- 转录组和基因组研究揭示了PD中的寡二细胞和髓完整性的改变.
结论:
- 白质异常是由髓和寡细胞的变化驱动的,是帕金森病病理学的组成部分.
- 这些髓/橄基细胞的变化代表了帕金森病治疗的潜在治疗点.
- 了解WM变化提供了更全面的看法,除了灰质之外的PD病原体.
更多相关视频
06:07Author Spotlight: Establishing a New Fluorescence-Based Protocol for In Vivo Mitochondrial Morphology Analysis in Parkinson's Disease
Published on: June 23, 2023
1.6K
10:03Studying Pre-formed Fibril Induced α-Synuclein Accumulation in Primary Embryonic Mouse Midbrain Dopamine Neurons
Published on: August 16, 2020
10.6K
相关概念视频
Parkinson's Disease: Overview
564
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
564
Neural Regulation
39.5K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
39.5K
Parkinson's Disease: Treatment
281
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
281
Brainstem
2.1K
The brainstem, located inferior to the brain and superior to the spinal cord, serves as a bridge between the cerebrum and the spinal cord. It plays a vital role in relaying information and controlling critical life functions. It comprises three primary regions: the midbrain, pons, and medulla oblongata.
The Midbrain
The midbrain is located beneath the diencephalon and connects the cerebrum with the lower parts of the brain. The cerebral peduncles are prominent midbrain structures that house the...
The Midbrain
The midbrain is located beneath the diencephalon and connects the cerebrum with the lower parts of the brain. The cerebral peduncles are prominent midbrain structures that house the...
2.1K
Alzheimer's Disease: Overview
498
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
498
